Abstract
OBJECTIVE: To determine the cost-effectiveness of management strategies for dysuria in different office settings.
DESIGN: Decision and cost-effectiveness analyses, assuming the payer’s perspective. Data on disease prevalence, test characteristics, treatment efficacy, and adverse effects were drawn from the English language literature using medline searches and bibliographies.
SETTING: Hypothetical primary care practice.
PATIENTS: Otherwise healthy, nonpregnant women with symptoms of dysuria, urgency, and frequency.
INTERVENTIONS: All reasonable combinations of urinalysis, urine culture, pelvic examination, chlamydia and gonorrhea cultures, and empiric treatment with trimethoprim-sulfamethoxazole.
RESULTS: The cost-effectiveness of strategies varied substantially among different patient settings. In all settings, empiric trimethoprim-sulfamethoxazole for all patients was least expensive and least effective. Most testing increased both cost and effectiveness. Compared to empiric antibiotics, performing pelvic examination and urine culture for women with normal urinalyses had a marginal cost-effectiveness ratio of $4 to $32 per symptom-day avoided (SDA). Adding urine culture for patients with pyuria had a marginal cost of $34 to $107 per SDA, which fell to $40/SDA when the prevalence of resistance to trimethoprim-sulfamethoxazole exceeded 40%. Pelvic examination and urine culture for all patients regardless of urinalysis results achieved the greatest benefit but at the highest cost (>$300 per SDA).
CONCLUSIONS: In otherwise healthy women with symptoms of dysuria and no vaginal complaints, performing pelvic exam and urine culture based on urinalysis offers a reasonable alternative to empiric therapy. Other testing may be warranted, depending on antibiotic resistance and the value of avoiding a day of dysuria.
Similar content being viewed by others
References
Hooton T, Stamm W. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:551–81.
Johnson J, Stamm W. Diagnosis and treatment of acute urinary tract infections. Infect Dis Clin North Am. 1987;1:773–91.
Barry H, Ebell M, Hickner J. Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies. J Fam Pract. 1997;44:49–60.
Carlson K, Mulley A. Management of acute dysuria. A decision-analysis model of alternative strategies. Ann Intern Med. 1985;102:244–9.
Greenfield S, Friedland G, Scifers S, Rhodes A, Black W, Komaroff A. Protocol management of dysuria, urinary frequency, and vaginal discharge. Ann Intern Med. 1974;81:452–7.
Greenfield S, Friedland G, Scifers S, Rhodes A, Black W, Komaroff A. Protocol management of dysuria, urinary frequency, and vaginal discharge. J Fam Pract. 1975;2:179–84.
Hooton T, Stamm W. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am. 1991;75:339–57.
Hooton T, Winter C, Tiu F, Stamm W. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA. 1995;273:41–5.
Hooton T. A simplified approach to urinary tract infection. Hosp Pract (Off Ed). 1995;30:23–30.
Johnson J, Stamm W. Urinary tract infections in women: diagnosis and treatment. Ann Intern Med. 1989;111:906–17.
Komaroff A, Pass T, McCue J, Cohen A, Hendricks T, Friedland G. Management strategies for urinary and vaginal infections. Arch Intern Med. 1978;138:1069–73.
Latham R, Wong E, Larson A, Coyle M, Stamm W. Laboratory diagnosis of urinary tract infection in ambulatory women. JAMA. 1985;254:3333–6.
Ramirez-Ronda C, Colon M, Saavedra S, Sabbaj J, Corrado M. Treatment of urinary tract infection with norfloxacin. Analysis of cost. Am J Med. 1987;82:75–8.
Patton J, Nash D, Abrutyn E. Urinary tract infection: economic considerations. Med Clin North Am. 1991;75:495–513.
Schultz H, McCaffrey L, Keys T, Nobrega F. Acute cystitis: a prospective study of laboratory tests and duration of therapy. Mayo Clin Proc. 1984;59:391–7.
Stamm W. Protocol for diagnosis of urinary tract infection: reconsidering the criterion for significant bacteriuria. Urology. 1988;32:6–12.
Stamm W, Hooton T. Management of urinary tract infections in adults. New Engl J Med. 1993;329:1328–34.
Saint S, Scholes D, Fihn SD, Farrell RG, Stamm WE. The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women. Am J Med. 1999;106:636–41.
Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002;287:2701–10.
Berg A. variations among family physicians’ management strategies for lower urinary tract infection in women: a report from the Washington Family Physicians Collaborative Research Network. J Am Board Fam Pract. 1991;4:327–30.
Wong E, Fennell C, Stamm W. Urinary tract infection among women attending a clinic for sexually transmitted diseases. Sex Transm Dis. 1984;11:18–23.
Frye C, Weisberg R. Increasing the incidence of routine pelvic examinations: behavioral medicine’s contribution. Women Health. 1994;21:33–55.
Lau J, Kassirer J, Pauker S. Decision Maker 3.0: improved decision analysis by personal computer. Med Decis Making. 1983;3:39–43.
Pauker S, Kassirer J. Clinical decision analysis by personal computer. Arch Intern Med. 1981;141:1831–7.
Gilbert D, Moellering R, Sande M. The Sanford Guide to Antimicrobial Therapy. Hyde Park, Vt: Antimicrobial Therapy, Inc; 2002.
Hooton T, Stamm W. Overview of acute cystitis. UpToDate. 2002. Available at: http://www.utdol.com/application/topic.asp?file=uti_infe/6763&type=A&selectedTitle=3~78. Accessed February 24, 2003.
Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001;135:41–50.
Asbach H. Single dose oral administration of cefixime 400 mg in the treatment of acute uncomplicated cystitis and gonorrhoea. Drugs. 1991;42(suppl 4):10–3.
Fihn S, Johnson C, Roberts P, Running K, Stamm W. Trimethoprim-sulfamethoxazole for acute dysuria in women: a single-dose or 10-day course. A double-blind, randomized trial. Ann Intern Med. 1988;108:350–7.
Gossius G, Vorland L. A randomised comparison of single-dose vs. three-day and ten-day therapy with trimethoprim-sulfamethoxazole for acute cystitis in women. Scand J Infect Dis. 1984;16:373–9.
Greenberg R, Reilly P, Luppen K, Weinandt W, Ellington L, Bollinger M. Randomized study of single-dose, three-day, and seven-day treatment of cystitis in women. J Infect Dis. 1986;153:277–82.
Hooton T, Running K, Stamm W. Single-dose therapy for cystitis in women. A comparison of trimethoprim-sulfamethoxazole, amoxicillin, and cyclacillin. JAMA. 1985;253:387–90.
Hooton T, Johnson C, Winter C, et al. Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agents Chemother. 1991;35:1479–83.
Tolkoff-Rubin N, Weber D, Fang L, Kelly M, Wilkinson R, Rubin R. Single-dose therapy with trimethoprim-sulfamethoxazole for urinary tract infection in women. Rev Infect Dis. 1982;4:444–8.
Stamm W, Counts G, Running K, Fihn S, Turck M, Holmes K. Diagnosis of coliform infection in acutely dysuric women. New Engl J Med. 1982;307:463–8.
Trienekens T, Stobberingh E, Winkens R, Houben A. Different lengths of treatment with co-trimoxazole for acute uncomplicated urinary tract infections in women. BMJ. 1989;299:1319–22.
Charlton C, Crowther A, Davies J, et al. Three-day and ten-day chemotherapy for urinary tract infections in general practice. Br Med J. 1976;1:124–6.
Tapsall J, Taylor P, Bell S, Smith D. Letter: Relevance of “significant bacteriuria” to aetiology and diagnosis of urinary-tract infection. Lancet. 1976;1:373.
Dans P, Klaus B. Dysuria in women. Johns Hopkins Med J. 1976;138:13–8.
Gallagher D, Montgomerie J, North J. Acute infections of the urinary tract and the urethral syndrome in general practice. BMJ. 1965;1:622–6.
Iravani A. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am J Med. 1993;94:89S-96S.
Brooks D, Maudar A. Pathogenesis of the urethral syndrome in women and its diagnosis in general practice. Lancet. 1972;2:893–8.
Mond N, Percival A, Williams J, Brumfitt W. Presentation, diagnosis and treatment of urinary-tract infections in general practice. Lancet. 1965;514–6.
Stamm W, Wagner K, Amsel R, et al. Causes of the acute urethral syndrome in women. New Engl J Med. 1980;303:409–15.
Berg A, Heidrich F, Fihn S, et al. Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology. JAMA. 1984;251:620–5.
Lachs M, Nachamkin I, Edelstein P, Goldman J, Feinstein A, Schwartz J. Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med. 1992;117:135–40.
Chernow B, Zaloga G, Soldano S, et al. Measurement of urinary leukocyte esterase activity: a screening test for urinary tract infections. Ann Emerg Med. 1984;13:150–4.
Sellors J, Mahony J, Pickard L, et al. Screening urine with a leukocyte esterase strip and subsequent chlamydial testing of asymptomatic men attending primary care practitioners. Sex Transm Dis. 1993;20:152–7.
Veervahu M, Smyth R, Clay J. Detection of leukocyte esterase in urine: a new screening test for nongonococcal urethritis compared with two microscopic methods. Sex Transm Dis. 1987;14:180–4.
Shafer M, Schachter J, Moscicki A, et al. Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. JAMA. 1989;262:2562–6.
Desai K, Robson H. Comparison of the Gram-stained urethral smear and the first-voided sediment in the diagnosis of nongonococcal urethritis. Sex Transm Dis. 1982;9:21–5.
Block J, Walstad R, Bjertnaes A, et al. Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. Drugs. 1987;34(suppl 1):100–6.
Sigurdsson J, Ahlmen J, Berglund L, et al. Three-day treatment of acute lower urinary tract infections in women. A double-blind study with amoxycillin and co-trimazine. Acta Med Scand. 1983;213:55–60.
Sabbaj J, Hoagland V, Shih W. Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections. Antimicrob Agents Chemother. 1985;27:297–301.
Hooton T, Latham R, Wong E, Johnson C, Roberts P, Stamm W. Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. Antimicrob Agents Chemother. 1989;33:1308–12.
Stein G, Mummaw N, Goldstein E, et al. A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections. Arch Intern Med. 1987;147:1760–2.
Iravani A, Tice A, McCarty J, et al. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group. Arch Intern Med. 1995;155:485–94.
Anonymous. Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. The Inter-Nordic Urinary Tract Infection Study Group. Scand J Infect Dis. 1988;20:619–24.
Ludwig G, Pauthner H. Clinical experience with ofloxacin in upper and lower urinary tract infections. A comparison with co-trimoxazole and nitrofurantoin. Drugs. 1987;34(suppl 1):95–9.
Trienekens T, London N, Houben A, De Jong R, Stobberingh E. Treating acute urinary tract infections. An RCT of 3-day versus 7-day norfloxacin. Can Fam Physician. 1993;39:514–8.
Anonymous. Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group. J Infect Dis. 1987;155:170–7.
Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis. 2001;33:89–94.
McCarty JM, Richard G, Huck W, et al. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med. 1999;106:292–9.
Stamm W, Running K, McKevitt M, Counts G, Turck M, Holmes K. Treatment of the acute urethral syndrome. New Engl J Med. 1981;304:956–8.
Brooks D, Garrett G, Hollihead R. Sulphadimidine, co-trimoxazole, and a placebo in the management of symptomatic urinary tract infection in general practice. JR Coll Gen Pract. 1972;22:695–703.
Charlton C. The urethral syndrome. Practitioner. 1979;223:333–7.
Baerheim A, Digranes A, Hunskaar S. Equal symptomatic outcome after antibacterial treatment of acute lower urinary tract infection and the acute urethral syndrome in adult women. Scand J Prim Health Care. 1999;17:170–3.
Mabeck C. Treatment of uncomplicated urinary tract infection in non-pregnant women. Postgrad Med J. 1972;48:69–75.
Hooper D, Wolfson J. Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects. Antimicrob Agents Chemother. 1989;33:1662–7.
Jick H, Derby L. A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity. Pharmacotherapy. 1995;15:428–32.
Jick S, Jick H, Dean A. A follow-up safety study of ciprofloxacin users. Pharmacotherapy. 1993;13:461–4.
Stamm W, McKevitt M, Roberts P, White N. Natural history of recurrent urinary tract infections in women. Rev Infect Dis. 1991;13:77–84.
National Physician Fee Schedule Relative Value File. Centers for Medicare & Medicaid Services; 2003. Available at: http://cms.hhs.gov/providers/pufdownload/rvudown.asp. Accessed February 27, 2003.
St. Anthony’s DRG Guidebook 1997 (Annual). Reston, Va: Saint Anthony’s Publishing, Inc.; 1996.
Government U. Physician Fee Schedule Update for Calendar Year 1997 and Physician Volume Performance Standard Rates of Increase for Federal Fiscal Year 1997. Fed Regist. 1996;61:59489–539.
Wasserman Y. Physicians’ Fee Reference. 13 ed. West Allis, Wis: Medical Publishers, Ltd.; 1996:350.
Hummers-Pradier E, Denig P, Oke T, Lagerlov P, Wahlstrom R, Haaijer-Ruskamp FM. GPs’ treatment of uncomplicated urinary tract infections—a clinical judgement analysis in four European countries. DEP group. Drug Education Project. Fam Pract. 1999;16:605–7.
Pauker S, Kassirer J. The threshold approach to clinical decision making. New Engl J Med. 1980;302:1109–17.
Fair W, Fair W III. Clinical value of sensitivity determinations in treating urinary tract infections. Urology. 1982;19:565–9.
Dean R, Herlihy E, McGuire E. The accuracy of antimicrobial disk sensitivity testing in urinary tract infections. J Urol. 1978;120:80–1.
Sanders G, Nease RJ, Owens D. Design and pilot evaluation of a system to develop computer-based site-specific practice guidelines from decision models. Med Decis Making. 2000;20:145–59.
Israel R, Lowenstein S, Marx J, Koziol-McLain J, Svoboda L, Ranniger S. Management of acute pyelonephritis in an emergency department observation unit. Ann Emerg Med. 1991;20:253–7.
Ward G, Jorden R, Severance H. Treatment of pyelonephritis in an observation unit. Ann Emerg Med. 1991;20:258–61.
Safrin S, Siegel D, Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med. 1988;85:793–8.
Average Length of Stay for Discharges from Short-stay Hospitals, by Age and First-listed Diagnosis: United States, 1998. National Center for Health Statistics; 2003. Available at: http://www.cdc.gov/nchs/data/hdasd/sr13_148t9.pdf. Accessed February 27, 2003.
Clinical Diagnostic Laboratory Fee Schedule. Centers for Medicare & Medicaid Services; 2003. Available at: http://cms.hhs.gov/providers/pufdownload/clfdown.asp. Accessed February 27, 2003.
The MEDSTAT Group. 2000 DRG Guide: Descriptions and Normative Values. Ann Arbor, Mich; 2001.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr. Rothberg was a National Library of Medicine Medical Informatics Research Fellow. Supported in part by grant #LM0709207 from the National Library of Medicine, Bethesda, Md.
Rights and permissions
About this article
Cite this article
Rothberg, M.B., Wong, J.B. All dysuria is local. J GEN INTERN MED 19, 433–443 (2004). https://doi.org/10.1111/j.1525-1497.2004.10440.x
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2004.10440.x